DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 155 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $121,943,897 | +21.2% | 8,256,188 | +6.0% | 0.01% | +40.0% |
Q2 2023 | $100,625,702 | +14.7% | 7,788,367 | -12.9% | 0.01% | 0.0% |
Q1 2023 | $87,736,953 | -58.7% | 8,943,648 | -55.2% | 0.01% | -16.7% |
Q4 2022 | $212,640,486 | +98.2% | 19,985,008 | +94.5% | 0.01% | -14.3% |
Q3 2022 | $107,263,000 | -1.3% | 10,274,230 | +19.1% | 0.01% | 0.0% |
Q2 2022 | $108,644,000 | +17.9% | 8,629,427 | +1.5% | 0.01% | +40.0% |
Q1 2022 | $92,126,000 | +4.8% | 8,498,732 | +36.1% | 0.01% | +25.0% |
Q4 2021 | $87,872,000 | -12.3% | 6,245,356 | +19.8% | 0.00% | -20.0% |
Q3 2021 | $100,166,000 | +45.0% | 5,214,257 | -25.6% | 0.01% | +25.0% |
Q2 2021 | $69,059,000 | -0.8% | 7,011,079 | -1.0% | 0.00% | 0.0% |
Q1 2021 | $69,633,000 | +43.7% | 7,083,764 | -34.9% | 0.00% | +33.3% |
Q4 2020 | $48,448,000 | -3.3% | 10,887,296 | -6.2% | 0.00% | 0.0% |
Q3 2020 | $50,125,000 | +11.7% | 11,603,107 | +129.4% | 0.00% | 0.0% |
Q2 2020 | $44,871,000 | +271.8% | 5,058,784 | +48.0% | 0.00% | +200.0% |
Q1 2020 | $12,068,000 | -38.7% | 3,418,712 | -0.7% | 0.00% | 0.0% |
Q4 2019 | $19,692,000 | +273.7% | 3,442,677 | +133.6% | 0.00% | – |
Q3 2019 | $5,270,000 | -0.9% | 1,474,025 | +10.6% | 0.00% | – |
Q2 2019 | $5,319,000 | -80.3% | 1,333,096 | -63.9% | 0.00% | -100.0% |
Q1 2019 | $26,961,000 | -2.4% | 3,688,249 | +22.2% | 0.00% | -33.3% |
Q4 2018 | $27,619,000 | -46.9% | 3,018,416 | -28.1% | 0.00% | -25.0% |
Q3 2018 | $52,054,000 | -37.6% | 4,198,059 | -23.2% | 0.00% | -42.9% |
Q2 2018 | $83,373,000 | -6.5% | 5,467,391 | +21.8% | 0.01% | -12.5% |
Q1 2018 | $89,133,000 | +4.1% | 4,490,070 | -2.0% | 0.01% | +14.3% |
Q4 2017 | $85,650,000 | +29.6% | 4,580,113 | +49.0% | 0.01% | +16.7% |
Q3 2017 | $66,084,000 | +716.0% | 3,073,692 | +266.3% | 0.01% | +500.0% |
Q2 2017 | $8,099,000 | +94.0% | 839,218 | +19.7% | 0.00% | – |
Q1 2017 | $4,174,000 | +49.8% | 701,106 | -0.6% | 0.00% | – |
Q4 2016 | $2,786,000 | -82.9% | 705,640 | -54.4% | 0.00% | -100.0% |
Q3 2016 | $16,247,000 | -29.0% | 1,548,561 | -1.4% | 0.00% | 0.0% |
Q2 2016 | $22,896,000 | -28.5% | 1,570,554 | -5.7% | 0.00% | -33.3% |
Q1 2016 | $32,038,000 | +18.7% | 1,665,452 | +49.1% | 0.00% | 0.0% |
Q4 2015 | $26,991,000 | -16.9% | 1,117,142 | -15.6% | 0.00% | -25.0% |
Q3 2015 | $32,487,000 | -17.2% | 1,323,958 | -20.9% | 0.00% | 0.0% |
Q2 2015 | $39,219,000 | +25.8% | 1,674,364 | +20.4% | 0.00% | +33.3% |
Q1 2015 | $31,184,000 | +72.9% | 1,390,451 | +29.9% | 0.00% | +50.0% |
Q4 2014 | $18,041,000 | +44.5% | 1,070,062 | -87.7% | 0.00% | +100.0% |
Q3 2014 | $12,483,000 | – | 8,726,806 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |